aua 成人尿动力学（ADULT URODYNAMICS）

Guideline Statements

Stress Urinary Incontinence /Prolapse

压力性尿失禁/脱垂

1. Clinicians who are making the diagnosis of urodynamic stress incontinence should assess urethral function.

1. 临床医生如果要做出尿动力学压力性尿失禁的诊断应评估尿道功能。

2. Surgeons considering invasive therapy in patients with SUI should assess post void residual urine volume.

2. 外科医师准备给压力性尿失禁患者进行侵入性治疗前需评估残余尿量。

3. Clinicians may perform multi-channel urodynamics in patients with both symptoms and physical findings of stress incontinence who are considering invasive, potentially morbid or irreversible treatments.

3. 对症状及查体发现压力性尿失禁的患者，临床医师在准备进行侵入性、有潜在并发症风险的或不可逆性的治疗以前，建议患者进行多通道尿动力学检查。

4. Clinicians should perform repeat stress testing with the urethral catheter removed in patients suspected of having SUI who do not demonstrate this finding with the catheter in place during urodynamic testing.

4. 对怀疑患有压力性尿失禁的患者，如果在尿动力学检查过程中因测压导管阻塞未诱发出尿失禁，临床医师应将测压导管拔出，重复压力测试。

5. Clinicians should perform stress testing with reduction of the prolapse in women with high grade pelvic organ prolapse but without the symptom of SUI. Multi-channel urodynamics with prolapse reduction may be used to assess for occult stress incontinence and detrusor dysfunction in these women with associated LUTS.

5. 对于合并重度盆腔脏器脱垂而没有压力性尿失禁症状的患者，临床医师应将脱垂器官复位后进行压力测试。复位脱垂器官后进行多通道尿动力学检查，可用于评估这些有下尿路症状的隐匿的女性压力性尿失禁患者以及合并逼尿肌功能障碍的患者。

Overactive Bladder , Urgency Urinary Incontinence，Mixed Incontinence

膀胱过度活动症，急迫性尿失禁，混合性尿失禁

6. Clinicians may perform multi-channel filling cystometry when it is important to determine if altered compliance, detrusor overactivity or other urodynamic abnormalities are present in patients with urgency incontinence in whom invasive, potentially morbid or irreversible treatments are considered.

6. 当急迫性尿失禁患者在准备实施侵入性的、有潜在并发症风险的、或不可逆性的治疗以前，临床医生进行多通道膀胱压力测定，明确患者是否有膀胱顺应性改变、逼尿肌过度活动或其他尿动力学异常非常重要。

7. Clinicians may perform pressure flow studies in patients with urgency incontinence after bladder outlet procedures to evaluate for bladder outlet obstruction.

7. 推荐临床医师对膀胱出口术后急迫性尿失禁的患者进行压力-流率测定评估膀胱出口梗阻的程度。

8. Clinicians should counsel patients with urgency incontinence and mixed incontinence that the absence of detrusor overactivity on a single urodynamic study does not exclude it as a causative agent for their symptoms.

8．临床医师应告知急迫性尿失禁和混合性尿失禁的患者，单次尿动力学检查未发现逼尿肌过度活动并不能排除DO不是症状产生的原因之一。

Neurogenic Bladder

神经源性膀胱

9. Clinicians should perform PVR assessment, either as part of a complete urodynamic study or separately, during the initial urological evaluation of patients with relevant neurological conditions and as part of ongoing follow-up when appropriate.

9. 临床医师在对有相关神经系统疾病史的患者进行泌尿系初步评估时应进行残余尿量测定。残余尿量测定既可以作为尿动力学检查的一部分，也可以单独测定，或根据情况可作为随访的复查项目。

10. Clinicians should perform a complex cystometrogram during initial urological evaluation of patients with relevant neurological conditions with or without symptoms and as part of ongoing follow-up when appropriate. In patients with other neurological diseases, physicians may consider CMG as an option in the urological evaluation of patients with LUTS.

10. 无论是否有症状，临床医师在对具有相关神经系统疾病史的患者进行初步泌尿系统评估时应进行完整的充盈期膀胱测压检查，根据情况还可作为随访复查的项目。对于患有其他神经系统疾病史的患者，推荐有下尿路症状的患者泌尿系统评估时进行充盈期膀胱测压。

11. Clinicians should perform pressure flow analysis during the initial urological evaluation of patients with relevant neurological conditions with or without symptoms and as part of ongoing follow-up when appropriate, in patients with other neurologic disease and elevated PVR or in patients with persistent symptoms.

11. 无论是否有症状，临床医师在对具有相关神经系统疾病史的患者进行初步泌尿系统评估时应进行压力流率分析，并可作为伴有相关神经系统疾病史、残余尿量增加患者，或伴有持续症状患者随访的一部分。

12. When available, clinicians may perform fluoroscopy at the time of urodynamics in patients with relevant neurologic disease at risk for neurogenic bladder, in patients with other neurologic disease and elevated PVR or in patients with urinary symptoms.

12. 如果条件允许，对患有神经源性膀胱风险的相关神经系统疾病史的患者、伴有其他神经性疾病和残余尿量增加的患者、或有尿路症状的患者进行尿动力学检查时，临床医生可同时进行影像学检查。

13. Clinicians should perform electromyography in combination with CMG with or without PFS in patients with relevant neurologic disease at risk for neurogenic bladder, in patients with other neurologic disease and elevated PVR or in patients with urinary symptoms.

13. 对患有神经源性膀胱风险的有相关神经系统疾病史的患者、或伴有其他神经性疾病和残余尿量增加的患者、以及有尿路症状的患者，临床医生实施充盈期膀胱测压检查时应同期行肌电图检查

LUTS

下尿路症状

14. Clinicians may perform PVR in patients with LUTS as a safety measure to rule out significant urinary retention both initially and during follow up.

14. 在初诊和随访期间，临床医生应对LUTS患者进行残余尿量测定，作为排除严重尿潴留的一种安全措施。

15. Uroflow may be used by clinicians in the initial and ongoing evaluation of male patients with LUTS when an abnormality of voiding/emptying is suggested.

15. 对怀疑有排尿异常/排空障碍的男性LUTS患者，临床医生可以在初筛和随诊评估时行尿流率检查。

16. Clinicians may perform multi-channel filling cystometry when it is important to determine if DO or other abnormalities of bladder filling/urine storage are present in patients with LUTS, particularly when invasive, potentially morbid or irreversible treatments are considered.

16. 当需要明确LUTS患者是否存在逼尿肌过度活动或其它的膀胱充盈/尿液储存障碍时，特别是准备实施侵入性的、有潜在风险或不可逆性的治疗时，临床医生可进行多通道充盈期膀胱测压。

17. Clinicians should perform PFS in men when it is important to determine if urodynamic obstruction is present in men with LUTS, particularly when invasive, potentially morbid or irreversible treatments are considered.

17. 当需要明确男性LUTS患者是否存在尿动力学梗阻时，特别是准备实施侵入性的、有潜在风险的或不可逆性的治疗前，临床医生应对患者进行压力流率测定。

18. Clinicians may perform PFS in women when it is important to determine if obstruction is present.

18. 当需要明确女性患者是否存在尿路梗阻时，临床医生可以实施压力流率测定。

19. Clinicians may perform videourodynamics in properly selected patients to localize the level of obstruction, particularly for the diagnosis of primary bladder neck obstruction.

19. 临床医生可对经筛选的患者行影像尿动力学检查，以确定梗阻的水平，尤其是明确原发性膀胱颈梗阻的诊断。

*翻译仅供学习交流，不作为临床实践标准

PDF指南全文获取

方式一：

后台回复"20190528"获取链接